Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampicin effects on glucose homeostasis
NCT00985270Phase 4Completed
- Sponsor
- University of Oulu
- Start
- Sep 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Rifampicin with Placebo (2 arms). Primary endpoint: Fasting glucose. Started Sep 2009; status: completed.
02
Drugs
rifampicin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00985270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985270.